HCC Risk and Monitoring in Patients With Type 2 Diabetes

Clinical trial NCT07675187 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07675187
Sponsor: National Taiwan University Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes (T2DM)Hepatocellular Carcinoma (HCC)

Start date: 2026-07-01
Primary completion: 2028-12-31
Enrollment: 2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.